Cancer Incidence for the City of Rochester, 2016-2020
Source: New York State Cancer Registry
Site of Cancer | Males and Females | Males | Females | ||||||
---|---|---|---|---|---|---|---|---|---|
Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | |
All Invasive Malignant Tumors | 1,031.0 | 483.7 | 470.1-497.5 | 532.8 | 548.8 | 527.1-571.1 | 498.2 | 436.0 | 418.5-454.1 |
Oral cavity and pharynx | 26.6 | 12.2 | 10.2-14.6 | 19.0 | 19.1 | 15.3-23.5 | 7.6 | 6.2 | 4.3-8.6 |
Esophagus | 11.8 | 5.6 | 4.2-7.3 | 8.4 | 8.6 | 6.1-11.8 | 3.4 | 3.1 | 1.8-5.0 |
Stomach | 17.2 | 8.2 | 6.5-10.2 | 8.8 | 8.9 | 6.3-12.1 | 8.4 | 7.5 | 5.4-10.3 |
Colorectal | 82.8 | 40.3 | 36.4-44.5 | 44.6 | 46.5 | 40.3-53.3 | 38.2 | 35.2 | 30.2-40.7 |
Colon excluding rectum | 58.0 | 28.6 | 25.3-32.2 | 30.4 | 32.2 | 27.1-38.0 | 27.6 | 25.5 | 21.3-30.3 |
Rectum & rectosigmoid | 24.8 | 11.7 | 9.7-14.1 | 14.2 | 14.3 | 11.0-18.2 | 10.6 | 9.7 | 7.2-12.8 |
Liver / intrahepatic bile duct | 23.8 | 10.5 | 8.6-12.6 | 16.0 | 15.6 | 12.2-19.7 | 7.8 | 6.4 | 4.5-8.8 |
Pancreas | 32.4 | 15.6 | 13.2-18.3 | 15.2 | 16.2 | 12.6-20.5 | 17.2 | 15.2 | 12.1-19.0 |
Larynx | 10.4 | 4.7 | 3.5-6.2 | 7.6 | 7.5 | 5.2-10.5 | 2.8 | 2.6 | 1.4-4.4 |
Lung and bronchus | 162.4 | 74.4 | 69.2-79.9 | 86.6 | 89.1 | 80.5-98.4 | 75.8 | 63.4 | 57.0-70.3 |
Melanoma of the skin | 22.8 | 10.7 | 8.8-13.0 | 13.2 | 14.9 | 11.4-19.2 | 9.6 | 7.8 | 5.7-10.5 |
Female breast | 137.2 | 121.7 | 112.4-131.5 | ||||||
Cervix uteri | 8.8 | 8.6 | 6.1-11.6 | ||||||
Corpus uterus and NOS | 37.0 | 31.1 | 26.6-36.1 | ||||||
Ovary | 9.4 | 8.1 | 5.9-10.9 | ||||||
Prostate | 150.6 | 150.3 | 139.3-162.0 | ||||||
Testis | 6.4 | 5.4 | 3.6-7.9 | ||||||
Urinary bladder (incl. in situ) | 37.2 | 18.4 | 15.8-21.4 | 25.2 | 28.6 | 23.6-34.4 | 12.0 | 10.6 | 8.0-13.7 |
Kidney and renal pelvis | 48.0 | 22.6 | 19.8-25.8 | 29.6 | 29.5 | 24.8-34.9 | 18.4 | 16.8 | 13.4-20.7 |
Brain and other central nervous system | 12.4 | 5.6 | 4.3-7.3 | 6.2 | 6.1 | 4.1-8.9 | 6.2 | 5.3 | 3.5-7.6 |
Thyroid | 20.8 | 9.4 | 7.6-11.5 | 6.6 | 6.8 | 4.6-9.7 | 14.2 | 12.0 | 9.2-15.3 |
Hodgkin lymphoma | 5.2 | 2.2 | 1.4-3.3 | 3.8 | 3.4 | 2.0-5.5 | 1.4 | 1.0 | 0.4-2.2 |
Non-Hodgkin lymphomas | 37.0 | 17.9 | 15.3-20.8 | 20.4 | 21.9 | 17.6-26.8 | 16.6 | 15.2 | 12.0-19.0 |
Myeloma | 20.2 | 9.8 | 7.9-12.0 | 10.2 | 11.5 | 8.4-15.3 | 10.0 | 8.6 | 6.3-11.5 |
Leukemias | 25.2 | 12.2 | 10.1-14.6 | 14.4 | 15.4 | 11.9-19.5 | 10.8 | 9.3 | 6.9-12.3 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution. NOS = Not otherwise specified.